Literature DB >> 7766147

From in vitro to in vivo. Progress in the use of cultured cells for human therapy.

W Dalemans1.   

Abstract

The use of cultured cells with the ultimate goal of using the cells or their products for human therapy has experienced an exponential growth during the last decade. Stable cell cultures have been established and genetically modified to obtain high quality products for protein replacement therapy or vaccines. Cells have also been directly isolated from the human organism and, after their expansion in vitro, been retransferred as skin grafts for treatment of burns or for cancer therapy by activated lymphocytes. With the explosive development of molecular biology techniques, it is now possible to genetically modify ex vivo, cells derived from the human body. These modifications should allow targeted expression of therapeutic genes into specific cells which will, upon retransfer to the body, exert their therapeutic action in a diseased organism.

Entities:  

Mesh:

Year:  1994        PMID: 7766147     DOI: 10.1007/BF00749907

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  40 in total

1.  Gene therapy for cancer.

Authors:  S A Rosenberg
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

2.  At age 2, gene therapy enters a growth phase.

Authors:  L Thompson
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

Review 3.  Human gene therapy.

Authors:  W F Anderson
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

Review 4.  Non-viral approaches to gene therapy.

Authors:  M Cotten; E Wagner
Journal:  Curr Opin Biotechnol       Date:  1993-12       Impact factor: 9.740

Review 5.  Progress toward human gene therapy.

Authors:  M A Morsy; K Mitani; P Clemens; C T Caskey
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

6.  Adenovirus as an expression vector in muscle cells in vivo.

Authors:  B Quantin; L D Perricaudet; S Tajbakhsh; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

Authors:  S A Rosenberg; P Aebersold; K Cornetta; A Kasid; R A Morgan; R Moen; E M Karson; M T Lotze; J C Yang; S L Topalian
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

8.  Human keratinocyte cell culture for the burns patients--a preliminary report.

Authors:  X Fei; C S Seah; S T Lee
Journal:  Ann Acad Med Singap       Date:  1991-07       Impact factor: 2.473

Review 9.  Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy.

Authors:  G Forni; M Giovarelli; F Cavallo; M Consalvo; A Allione; A Modesti; P Musiani; M P Colombo
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-11

10.  Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.

Authors:  A Porgador; E Tzehoval; E Vadai; M Feldman; L Eisenbach
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10
View more
  1 in total

1.  Use of gene-modified keratinocytes and fibroblasts to enhance regeneration in a full skin defect.

Authors:  Jörn Andreas Lohmeyer; Fang Liu; Stefan Krüger; Werner Lindenmaier; Frank Siemers; Hans-Günther Machens
Journal:  Langenbecks Arch Surg       Date:  2011-03-03       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.